Zevra Therapeutics(DE:1GDA)
€10.65+0.45 (+14.52%)
DE:1GDA
Zevra Therapeutics Revenue
€10.65
At close:+0.45 (+14.52%)
Zevra Therapeutics (1GDA) Revenue
1 Followers
Zevra Therapeutics Revenue
Zevra Therapeutics had a revenue of 37.76M in the quarter ending Sep 30, 2026, with -4.81%. This bring the company's revenue in the last twelve months to 147.76M, Increased 8.59%. In the fiscal year ending Dec 31, 2025, Zevra Therapeutics had annual revenue of 106.47M with 350.91% growth.
- Revenue (ttm)
- 147.76M
- Revenue Growth
- 67.80%
- P/S Ratio
- 6.00
- Revenue/Employee
- EUR 1,745,410
- Employees
- 61
- Market Cap
- EUR 639.20M
Revenue Chart
Zevra Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 106.47M | 82.86M | 350.91% |
| Dec 31, 2024 | 23.61M | -3.85M | -14.02% |
| Dec 31, 2023 | 27.46M | 17.30M | 170.26% |
| Dec 31, 2022 | 10.16M | -18.49M | -64.53% |
| Dec 31, 2021 | 28.65M | 15.36M | 115.61% |
| Dec 31, 2020 | 13.29M | 449.00K | 3.50% |
| Dec 31, 2019 | 12.84M | 12.84M | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.